Report Overview
This report provides a deep insight into the global Tuberculosis Diagnostics and Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tuberculosis Diagnostics and Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tuberculosis Diagnostics and Treatment market in any manner.
Global Tuberculosis Diagnostics and Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cepheid Inc
Becton Dickinson
Hain LifeSciences
Abbott Laboratories
Alere, Inc
Roche AG
Hologic Corporation
bioMerieux
Sanofi
QIAGEN
Akonni Biosystems, Inc.
Epistem Holdings Plc
Gen-Probe Inc.
EIKEN Chemical
Thermo Fisher Scientific, Inc
Market Segmentation (by Type)
Skin Testing
Laboratory Testing
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Tuberculosis Diagnostics and Treatment Market
? Overview of the regional outlook of the Tuberculosis Diagnostics and Treatment Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Diagnostics and Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Tuberculosis Diagnostics and Treatment
1.2 Key Market Segments
1.2.1 Tuberculosis Diagnostics and Treatment Segment by Type
1.2.2 Tuberculosis Diagnostics and Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Tuberculosis Diagnostics and Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Tuberculosis Diagnostics and Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tuberculosis Diagnostics and Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Tuberculosis Diagnostics and Treatment Market Competitive Landscape
3.1 Global Tuberculosis Diagnostics and Treatment Sales by Manufacturers (2019-2024)
3.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Tuberculosis Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tuberculosis Diagnostics and Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tuberculosis Diagnostics and Treatment Sales Sites, Area Served, Product Type
3.6 Tuberculosis Diagnostics and Treatment Market Competitive Situation and Trends
3.6.1 Tuberculosis Diagnostics and Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tuberculosis Diagnostics and Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Tuberculosis Diagnostics and Treatment Industry Chain Analysis
4.1 Tuberculosis Diagnostics and Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Tuberculosis Diagnostics and Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Tuberculosis Diagnostics and Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tuberculosis Diagnostics and Treatment Sales Market Share by Type (2019-2024)
6.3 Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Tuberculosis Diagnostics and Treatment Price by Type (2019-2024)
7 Tuberculosis Diagnostics and Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tuberculosis Diagnostics and Treatment Market Sales by Application (2019-2024)
7.3 Global Tuberculosis Diagnostics and Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Tuberculosis Diagnostics and Treatment Sales Growth Rate by Application (2019-2024)
8 Tuberculosis Diagnostics and Treatment Market Segmentation by Region
8.1 Global Tuberculosis Diagnostics and Treatment Sales by Region
8.1.1 Global Tuberculosis Diagnostics and Treatment Sales by Region
8.1.2 Global Tuberculosis Diagnostics and Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Tuberculosis Diagnostics and Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tuberculosis Diagnostics and Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tuberculosis Diagnostics and Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tuberculosis Diagnostics and Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tuberculosis Diagnostics and Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Cepheid Inc
9.1.1 Cepheid Inc Tuberculosis Diagnostics and Treatment Basic Information
9.1.2 Cepheid Inc Tuberculosis Diagnostics and Treatment Product Overview
9.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Product Market Performance
9.1.4 Cepheid Inc Business Overview
9.1.5 Cepheid Inc Tuberculosis Diagnostics and Treatment SWOT Analysis
9.1.6 Cepheid Inc Recent Developments
9.2 Becton Dickinson
9.2.1 Becton Dickinson Tuberculosis Diagnostics and Treatment Basic Information
9.2.2 Becton Dickinson Tuberculosis Diagnostics and Treatment Product Overview
9.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Product Market Performance
9.2.4 Becton Dickinson Business Overview
9.2.5 Becton Dickinson Tuberculosis Diagnostics and Treatment SWOT Analysis
9.2.6 Becton Dickinson Recent Developments
9.3 Hain LifeSciences
9.3.1 Hain LifeSciences Tuberculosis Diagnostics and Treatment Basic Information
9.3.2 Hain LifeSciences Tuberculosis Diagnostics and Treatment Product Overview
9.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Product Market Performance
9.3.4 Hain LifeSciences Tuberculosis Diagnostics and Treatment SWOT Analysis
9.3.5 Hain LifeSciences Business Overview
9.3.6 Hain LifeSciences Recent Developments
9.4 Abbott Laboratories
9.4.1 Abbott Laboratories Tuberculosis Diagnostics and Treatment Basic Information
9.4.2 Abbott Laboratories Tuberculosis Diagnostics and Treatment Product Overview
9.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Product Market Performance
9.4.4 Abbott Laboratories Business Overview
9.4.5 Abbott Laboratories Recent Developments
9.5 Alere, Inc
9.5.1 Alere, Inc Tuberculosis Diagnostics and Treatment Basic Information
9.5.2 Alere, Inc Tuberculosis Diagnostics and Treatment Product Overview
9.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Product Market Performance
9.5.4 Alere, Inc Business Overview
9.5.5 Alere, Inc Recent Developments
9.6 Roche AG
9.6.1 Roche AG Tuberculosis Diagnostics and Treatment Basic Information
9.6.2 Roche AG Tuberculosis Diagnostics and Treatment Product Overview
9.6.3 Roche AG Tuberculosis Diagnostics and Treatment Product Market Performance
9.6.4 Roche AG Business Overview
9.6.5 Roche AG Recent Developments
9.7 Hologic Corporation
9.7.1 Hologic Corporation Tuberculosis Diagnostics and Treatment Basic Information
9.7.2 Hologic Corporation Tuberculosis Diagnostics and Treatment Product Overview
9.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Product Market Performance
9.7.4 Hologic Corporation Business Overview
9.7.5 Hologic Corporation Recent Developments
9.8 bioMerieux
9.8.1 bioMerieux Tuberculosis Diagnostics and Treatment Basic Information
9.8.2 bioMerieux Tuberculosis Diagnostics and Treatment Product Overview
9.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Product Market Performance
9.8.4 bioMerieux Business Overview
9.8.5 bioMerieux Recent Developments
9.9 Sanofi
9.9.1 Sanofi Tuberculosis Diagnostics and Treatment Basic Information
9.9.2 Sanofi Tuberculosis Diagnostics and Treatment Product Overview
9.9.3 Sanofi Tuberculosis Diagnostics and Treatment Product Market Performance
9.9.4 Sanofi Business Overview
9.9.5 Sanofi Recent Developments
9.10 QIAGEN
9.10.1 QIAGEN Tuberculosis Diagnostics and Treatment Basic Information
9.10.2 QIAGEN Tuberculosis Diagnostics and Treatment Product Overview
9.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Product Market Performance
9.10.4 QIAGEN Business Overview
9.10.5 QIAGEN Recent Developments
9.11 Akonni Biosystems, Inc.
9.11.1 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Basic Information
9.11.2 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product Overview
9.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product Market Performance
9.11.4 Akonni Biosystems, Inc. Business Overview
9.11.5 Akonni Biosystems, Inc. Recent Developments
9.12 Epistem Holdings Plc
9.12.1 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Basic Information
9.12.2 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product Overview
9.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product Market Performance
9.12.4 Epistem Holdings Plc Business Overview
9.12.5 Epistem Holdings Plc Recent Developments
9.13 Gen-Probe Inc.
9.13.1 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Basic Information
9.13.2 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product Overview
9.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product Market Performance
9.13.4 Gen-Probe Inc. Business Overview
9.13.5 Gen-Probe Inc. Recent Developments
9.14 EIKEN Chemical
9.14.1 EIKEN Chemical Tuberculosis Diagnostics and Treatment Basic Information
9.14.2 EIKEN Chemical Tuberculosis Diagnostics and Treatment Product Overview
9.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Product Market Performance
9.14.4 EIKEN Chemical Business Overview
9.14.5 EIKEN Chemical Recent Developments
9.15 Thermo Fisher Scientific, Inc
9.15.1 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Basic Information
9.15.2 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product Overview
9.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product Market Performance
9.15.4 Thermo Fisher Scientific, Inc Business Overview
9.15.5 Thermo Fisher Scientific, Inc Recent Developments
10 Tuberculosis Diagnostics and Treatment Market Forecast by Region
10.1 Global Tuberculosis Diagnostics and Treatment Market Size Forecast
10.2 Global Tuberculosis Diagnostics and Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tuberculosis Diagnostics and Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Tuberculosis Diagnostics and Treatment Market Size Forecast by Region
10.2.4 South America Tuberculosis Diagnostics and Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tuberculosis Diagnostics and Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Tuberculosis Diagnostics and Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tuberculosis Diagnostics and Treatment by Type (2025-2030)
11.1.2 Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tuberculosis Diagnostics and Treatment by Type (2025-2030)
11.2 Global Tuberculosis Diagnostics and Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Tuberculosis Diagnostics and Treatment Sales (K Units) Forecast by Application
11.2.2 Global Tuberculosis Diagnostics and Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tuberculosis Diagnostics and Treatment Market Size Comparison by Region (M USD)
Table 5. Global Tuberculosis Diagnostics and Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Tuberculosis Diagnostics and Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tuberculosis Diagnostics and Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tuberculosis Diagnostics and Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2022)
Table 10. Global Market Tuberculosis Diagnostics and Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tuberculosis Diagnostics and Treatment Sales Sites and Area Served
Table 12. Manufacturers Tuberculosis Diagnostics and Treatment Product Type
Table 13. Global Tuberculosis Diagnostics and Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tuberculosis Diagnostics and Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tuberculosis Diagnostics and Treatment Market Challenges
Table 22. Global Tuberculosis Diagnostics and Treatment Sales by Type (K Units)
Table 23. Global Tuberculosis Diagnostics and Treatment Market Size by Type (M USD)
Table 24. Global Tuberculosis Diagnostics and Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Tuberculosis Diagnostics and Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Tuberculosis Diagnostics and Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Tuberculosis Diagnostics and Treatment Market Size Share by Type (2019-2024)
Table 28. Global Tuberculosis Diagnostics and Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Tuberculosis Diagnostics and Treatment Sales (K Units) by Application
Table 30. Global Tuberculosis Diagnostics and Treatment Market Size by Application
Table 31. Global Tuberculosis Diagnostics and Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Tuberculosis Diagnostics and Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Tuberculosis Diagnostics and Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Tuberculosis Diagnostics and Treatment Market Share by Application (2019-2024)
Table 35. Global Tuberculosis Diagnostics and Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Tuberculosis Diagnostics and Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Tuberculosis Diagnostics and Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Tuberculosis Diagnostics and Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Tuberculosis Diagnostics and Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Tuberculosis Diagnostics and Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Tuberculosis Diagnostics and Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Tuberculosis Diagnostics and Treatment Sales by Region (2019-2024) & (K Units)
Table 43. Cepheid Inc Tuberculosis Diagnostics and Treatment Basic Information
Table 44. Cepheid Inc Tuberculosis Diagnostics and Treatment Product Overview
Table 45. Cepheid Inc Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Cepheid Inc Business Overview
Table 47. Cepheid Inc Tuberculosis Diagnostics and Treatment SWOT Analysis
Table 48. Cepheid Inc Recent Developments
Table 49. Becton Dickinson Tuberculosis Diagnostics and Treatment Basic Information
Table 50. Becton Dickinson Tuberculosis Diagnostics and Treatment Product Overview
Table 51. Becton Dickinson Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Becton Dickinson Business Overview
Table 53. Becton Dickinson Tuberculosis Diagnostics and Treatment SWOT Analysis
Table 54. Becton Dickinson Recent Developments
Table 55. Hain LifeSciences Tuberculosis Diagnostics and Treatment Basic Information
Table 56. Hain LifeSciences Tuberculosis Diagnostics and Treatment Product Overview
Table 57. Hain LifeSciences Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Hain LifeSciences Tuberculosis Diagnostics and Treatment SWOT Analysis
Table 59. Hain LifeSciences Business Overview
Table 60. Hain LifeSciences Recent Developments
Table 61. Abbott Laboratories Tuberculosis Diagnostics and Treatment Basic Information
Table 62. Abbott Laboratories Tuberculosis Diagnostics and Treatment Product Overview
Table 63. Abbott Laboratories Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Recent Developments
Table 66. Alere, Inc Tuberculosis Diagnostics and Treatment Basic Information
Table 67. Alere, Inc Tuberculosis Diagnostics and Treatment Product Overview
Table 68. Alere, Inc Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Alere, Inc Business Overview
Table 70. Alere, Inc Recent Developments
Table 71. Roche AG Tuberculosis Diagnostics and Treatment Basic Information
Table 72. Roche AG Tuberculosis Diagnostics and Treatment Product Overview
Table 73. Roche AG Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Roche AG Business Overview
Table 75. Roche AG Recent Developments
Table 76. Hologic Corporation Tuberculosis Diagnostics and Treatment Basic Information
Table 77. Hologic Corporation Tuberculosis Diagnostics and Treatment Product Overview
Table 78. Hologic Corporation Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Hologic Corporation Business Overview
Table 80. Hologic Corporation Recent Developments
Table 81. bioMerieux Tuberculosis Diagnostics and Treatment Basic Information
Table 82. bioMerieux Tuberculosis Diagnostics and Treatment Product Overview
Table 83. bioMerieux Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. bioMerieux Business Overview
Table 85. bioMerieux Recent Developments
Table 86. Sanofi Tuberculosis Diagnostics and Treatment Basic Information
Table 87. Sanofi Tuberculosis Diagnostics and Treatment Product Overview
Table 88. Sanofi Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Sanofi Business Overview
Table 90. Sanofi Recent Developments
Table 91. QIAGEN Tuberculosis Diagnostics and Treatment Basic Information
Table 92. QIAGEN Tuberculosis Diagnostics and Treatment Product Overview
Table 93. QIAGEN Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. QIAGEN Business Overview
Table 95. QIAGEN Recent Developments
Table 96. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Basic Information
Table 97. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product Overview
Table 98. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Akonni Biosystems, Inc. Business Overview
Table 100. Akonni Biosystems, Inc. Recent Developments
Table 101. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Basic Information
Table 102. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product Overview
Table 103. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Epistem Holdings Plc Business Overview
Table 105. Epistem Holdings Plc Recent Developments
Table 106. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Basic Information
Table 107. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product Overview
Table 108. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Gen-Probe Inc. Business Overview
Table 110. Gen-Probe Inc. Recent Developments
Table 111. EIKEN Chemical Tuberculosis Diagnostics and Treatment Basic Information
Table 112. EIKEN Chemical Tuberculosis Diagnostics and Treatment Product Overview
Table 113. EIKEN Chemical Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. EIKEN Chemical Business Overview
Table 115. EIKEN Chemical Recent Developments
Table 116. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Basic Information
Table 117. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product Overview
Table 118. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Thermo Fisher Scientific, Inc Business Overview
Table 120. Thermo Fisher Scientific, Inc Recent Developments
Table 121. Global Tuberculosis Diagnostics and Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Tuberculosis Diagnostics and Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Tuberculosis Diagnostics and Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Tuberculosis Diagnostics and Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Tuberculosis Diagnostics and Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Tuberculosis Diagnostics and Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Tuberculosis Diagnostics and Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Tuberculosis Diagnostics and Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Tuberculosis Diagnostics and Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Tuberculosis Diagnostics and Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Tuberculosis Diagnostics and Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Tuberculosis Diagnostics and Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Tuberculosis Diagnostics and Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Tuberculosis Diagnostics and Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Tuberculosis Diagnostics and Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tuberculosis Diagnostics and Treatment Market Size (M USD), 2019-2030
Figure 5. Global Tuberculosis Diagnostics and Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Tuberculosis Diagnostics and Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tuberculosis Diagnostics and Treatment Market Size by Country (M USD)
Figure 11. Tuberculosis Diagnostics and Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Tuberculosis Diagnostics and Treatment Revenue Share by Manufacturers in 2023
Figure 13. Tuberculosis Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tuberculosis Diagnostics and Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tuberculosis Diagnostics and Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tuberculosis Diagnostics and Treatment Market Share by Type
Figure 18. Sales Market Share of Tuberculosis Diagnostics and Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Tuberculosis Diagnostics and Treatment by Type in 2023
Figure 20. Market Size Share of Tuberculosis Diagnostics and Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Tuberculosis Diagnostics and Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tuberculosis Diagnostics and Treatment Market Share by Application
Figure 24. Global Tuberculosis Diagnostics and Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Tuberculosis Diagnostics and Treatment Sales Market Share by Application in 2023
Figure 26. Global Tuberculosis Diagnostics and Treatment Market Share by Application (2019-2024)
Figure 27. Global Tuberculosis Diagnostics and Treatment Market Share by Application in 2023
Figure 28. Global Tuberculosis Diagnostics and Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tuberculosis Diagnostics and Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Tuberculosis Diagnostics and Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Tuberculosis Diagnostics and Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Tuberculosis Diagnostics and Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Tuberculosis Diagnostics and Treatment Sales Market Share by Country in 2023
Figure 37. Germany Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Tuberculosis Diagnostics and Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Tuberculosis Diagnostics and Treatment Sales Market Share by Region in 2023
Figure 44. China Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Tuberculosis Diagnostics and Treatment Sales and Growth Rate (K Units)
Figure 50. South America Tuberculosis Diagnostics and Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Tuberculosis Diagnostics and Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Tuberculosis Diagnostics and Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Tuberculosis Diagnostics and Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Tuberculosis Diagnostics and Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tuberculosis Diagnostics and Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tuberculosis Diagnostics and Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Tuberculosis Diagnostics and Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Tuberculosis Diagnostics and Treatment Market Share Forecast by Application (2025-2030)
